Study tests standardized e-cigarette effects in people with HIV who smoke
Part of Infections clinical trials.
This study looks at how a specific e-cigarette affects health in people who have HIV and smoke cigarettes regularly. You might be able to join if you meet smoking, HIV care, and safety requirements and are not planning to quit right away.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have HIV, and you’ve been seen at an HIV clinic in the last 6 months
- You smoke at least 5 cigarettes per day for more than 1 year
- Your breath shows carbon monoxide above 5 (a sign of ongoing smoking)
- You are NOT planning to quit smoking within the next 30 days
- You are not using smoking-cessation medicines, and you’re using e-cigarettes no more than 2 days per week
- You don’t have certain unstable health/mental health issues, past suicidal thoughts/attempts, other drug use problems, or pregnancy/breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This trial tests ways to deliver tobacco-quit treatment more effectively for people living with HIV. You may help researchers compare different quit-support approaches to see what works best.
This study combines a medication to help people stop smoking with a custom mobile app, all within the Swiss HIV Cohort Study. It's designed for people living with HIV who smoke and want to quit.
This study tests a program in Nairobi, Kenya, that helps people living with HIV who smoke and drink heavily. The goal is to find the best way to help them quit both habits, which may improve their health.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.